To switch (from vitamin-K antagonist to NOAC) or not to switch – that's the question
- Torben Bjerregaard Larsen (Lecturer)
Activity: Talks and presentations › Talks and presentations in private or public companies
Activity: Talks and presentations › Talks and presentations in private or public companies